Brainsway Dtms denied as not FDA-approved for this use by Humana?

Humana's specific coverage criteria for brainsway dtms are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana May Deny BrainsWay Deep TMS as Not FDA-Approved

A "not FDA-approved" denial for BrainsWay Deep TMS is worth scrutinizing carefully, because BrainsWay Deep TMS is a medical device that operates under FDA clearance via the 510(k) pathway—not the drug-approval pathway. Humana may be applying a policy that uses "FDA-approved" language but actually requires FDA clearance, or the denial may reflect a mismatch between the specific indication being treated and the cleared indications listed on the device's 510(k) clearance.

This denial type is often overturned by providing the relevant FDA clearance documentation and, where applicable, demonstrating that the indication being treated is within the cleared scope.

## Federal Appeal Framework

• ACA §2719 / External Review: Independent external review is available for most non-grandfathered plans within approximately 4 months (180 days) of denial. External reviewers apply objective regulatory and clinical standards and are not bound by Humana's internal policy classifications.
• ERISA §503: Entitles you to a full-and-fair review, the specific criteria relied upon, and the right to submit additional evidence including regulatory documentation.
• Expedited review: Available when the clinical situation is urgent; decisions typically within 72 hours.

## Appeal Process and Timeline

1. Clarify the basis of the denial — request in writing precisely which FDA requirement Humana believes is unmet and which policy language it is applying. 2. Obtain the FDA 510(k) clearance documentation — the FDA's 510(k) database is publicly accessible. Download the clearance summary for BrainsWay Deep TMS covering the relevant indication. 3. Internal appeal — submit the clearance documentation with a prescriber letter explaining the cleared indication and how it applies to this patient's diagnosis. 4. External review — if the internal appeal is denied, an independent reviewer with clinical and regulatory expertise will evaluate the evidence.

## Documentation to Gather

• FDA 510(k) clearance documentation: The specific clearance summary for BrainsWay Deep TMS and the indication(s) it covers.
• Diagnosis confirmation: Chart notes and diagnostic coding confirming the condition falls within the cleared indication.
• Prescriber medical-necessity letter: Explains the device's regulatory status, the indication match, and the clinical rationale.
• Prior treatment history: Dates and outcomes of prior treatments, demonstrating this is a medically appropriate next step.
• Humana policy language: The exact language from Humana's coverage/medical policy that references FDA requirements, so you can respond to each element directly.

## Criteria-Mapping Structure

| Denial Basis | Rebuttal Evidence | |---|---| | Device lacks FDA approval/clearance | [510(k) clearance documentation for this indication] | | Indication mismatch | [Chart diagnosis mapped to cleared indication] | | Policy criterion for regulatory status | [Quote policy language; provide clearance response] | | Clinical appropriateness | [Prescriber letter + prior treatment history] |

If Humana's denial letter is imprecise about which regulatory standard is being applied, ask for clarification before filing your appeal. A precise response to the actual criterion is more effective than a general rebuttal.